Cargando…

Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation

Non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing challenge in terms of prevention and treatment. The aim of this study is to investigate the protective effects and the underlying mechanisms of vanadium(IV)-chlorodipicolinate ([V(IV)O(dipic-Cl)(H(2)O)(2), V...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanli, Chen, Rulong, Li, Jingyi, Zeng, Guodong, Yuan, Juntao, Su, Jingran, Wu, Chunyan, Lu, Zhongbing, Zhang, Fang, Ding, Wenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220021/
https://www.ncbi.nlm.nih.gov/pubmed/35739990
http://dx.doi.org/10.3390/antiox11061093
_version_ 1784732268593414144
author Wang, Yuanli
Chen, Rulong
Li, Jingyi
Zeng, Guodong
Yuan, Juntao
Su, Jingran
Wu, Chunyan
Lu, Zhongbing
Zhang, Fang
Ding, Wenjun
author_facet Wang, Yuanli
Chen, Rulong
Li, Jingyi
Zeng, Guodong
Yuan, Juntao
Su, Jingran
Wu, Chunyan
Lu, Zhongbing
Zhang, Fang
Ding, Wenjun
author_sort Wang, Yuanli
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing challenge in terms of prevention and treatment. The aim of this study is to investigate the protective effects and the underlying mechanisms of vanadium(IV)-chlorodipicolinate ([V(IV)O(dipic-Cl)(H(2)O)(2), VOdipic-Cl]) in a mouse model of NAFLD induced by a high-fat diet (HFD). VOdipic-Cl (10 mg/kg/day body weight) treatment for 4 weeks significantly controlled body weight gain, and effectively reduced the increase in serum and hepatic triglyceride (TG) and total cholesterol (TC) levels, mitigated pathological injury, decreased malondialdehyde (MDA) level, and inhibited endoplasmic reticulum (ER) stress and inflammatory response in the livers of C57BL/6 obese mice. Moreover, RNA-sequencing analysis revealed distinct transcriptional profiles with differentially expressed genes (DEGs) in livers. We found that VOdipic-Cl effectively down-regulated genes related to lipid synthesis and up-regulated genes related to fatty acid transport and lipolysis, and down-regulated the expression of genes related to ER stress and immune response in the livers of obese mice. In conclusion, VOdipic-Cl effectively prevented hepatic steatosis by controlling body weight, mitigating oxidative stress, and regulating the expression of genes related to lipid metabolism, ER stress and immune response, which provides new insights into the molecular mechanism of the protective effect of VOdipic-Cl against hepatic steatosis.
format Online
Article
Text
id pubmed-9220021
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92200212022-06-24 Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation Wang, Yuanli Chen, Rulong Li, Jingyi Zeng, Guodong Yuan, Juntao Su, Jingran Wu, Chunyan Lu, Zhongbing Zhang, Fang Ding, Wenjun Antioxidants (Basel) Article Non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing challenge in terms of prevention and treatment. The aim of this study is to investigate the protective effects and the underlying mechanisms of vanadium(IV)-chlorodipicolinate ([V(IV)O(dipic-Cl)(H(2)O)(2), VOdipic-Cl]) in a mouse model of NAFLD induced by a high-fat diet (HFD). VOdipic-Cl (10 mg/kg/day body weight) treatment for 4 weeks significantly controlled body weight gain, and effectively reduced the increase in serum and hepatic triglyceride (TG) and total cholesterol (TC) levels, mitigated pathological injury, decreased malondialdehyde (MDA) level, and inhibited endoplasmic reticulum (ER) stress and inflammatory response in the livers of C57BL/6 obese mice. Moreover, RNA-sequencing analysis revealed distinct transcriptional profiles with differentially expressed genes (DEGs) in livers. We found that VOdipic-Cl effectively down-regulated genes related to lipid synthesis and up-regulated genes related to fatty acid transport and lipolysis, and down-regulated the expression of genes related to ER stress and immune response in the livers of obese mice. In conclusion, VOdipic-Cl effectively prevented hepatic steatosis by controlling body weight, mitigating oxidative stress, and regulating the expression of genes related to lipid metabolism, ER stress and immune response, which provides new insights into the molecular mechanism of the protective effect of VOdipic-Cl against hepatic steatosis. MDPI 2022-05-31 /pmc/articles/PMC9220021/ /pubmed/35739990 http://dx.doi.org/10.3390/antiox11061093 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Yuanli
Chen, Rulong
Li, Jingyi
Zeng, Guodong
Yuan, Juntao
Su, Jingran
Wu, Chunyan
Lu, Zhongbing
Zhang, Fang
Ding, Wenjun
Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation
title Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation
title_full Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation
title_fullStr Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation
title_full_unstemmed Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation
title_short Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation
title_sort vanadium(iv)-chlorodipicolinate protects against hepatic steatosis by ameliorating lipid peroxidation, endoplasmic reticulum stress, and inflammation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220021/
https://www.ncbi.nlm.nih.gov/pubmed/35739990
http://dx.doi.org/10.3390/antiox11061093
work_keys_str_mv AT wangyuanli vanadiumivchlorodipicolinateprotectsagainsthepaticsteatosisbyamelioratinglipidperoxidationendoplasmicreticulumstressandinflammation
AT chenrulong vanadiumivchlorodipicolinateprotectsagainsthepaticsteatosisbyamelioratinglipidperoxidationendoplasmicreticulumstressandinflammation
AT lijingyi vanadiumivchlorodipicolinateprotectsagainsthepaticsteatosisbyamelioratinglipidperoxidationendoplasmicreticulumstressandinflammation
AT zengguodong vanadiumivchlorodipicolinateprotectsagainsthepaticsteatosisbyamelioratinglipidperoxidationendoplasmicreticulumstressandinflammation
AT yuanjuntao vanadiumivchlorodipicolinateprotectsagainsthepaticsteatosisbyamelioratinglipidperoxidationendoplasmicreticulumstressandinflammation
AT sujingran vanadiumivchlorodipicolinateprotectsagainsthepaticsteatosisbyamelioratinglipidperoxidationendoplasmicreticulumstressandinflammation
AT wuchunyan vanadiumivchlorodipicolinateprotectsagainsthepaticsteatosisbyamelioratinglipidperoxidationendoplasmicreticulumstressandinflammation
AT luzhongbing vanadiumivchlorodipicolinateprotectsagainsthepaticsteatosisbyamelioratinglipidperoxidationendoplasmicreticulumstressandinflammation
AT zhangfang vanadiumivchlorodipicolinateprotectsagainsthepaticsteatosisbyamelioratinglipidperoxidationendoplasmicreticulumstressandinflammation
AT dingwenjun vanadiumivchlorodipicolinateprotectsagainsthepaticsteatosisbyamelioratinglipidperoxidationendoplasmicreticulumstressandinflammation